Integrative proteo-metabolomic analysis in rheumatoid arthritis reveals potential therapeutic targets: Harnessing Mendelian randomization - Canadian Longitudinal Study on Aging (CLSA)

Integrative proteo-metabolomic analysis in rheumatoid arthritis reveals potential therapeutic targets: Harnessing Mendelian randomization

Almars AI, Alhashemi MH, Kattan SW, Alsulaimani F, Basri AM, ALMatrafi TA, Althobaiti NA, BinMowyna...

Almars AI, Alhashemi MH, Kattan SW, Alsulaimani F, Basri AM, ALMatrafi TA, Althobaiti NA, BinMowyna MN, Almohaimeed HM, Soliman MH. Integrative proteo-metabolomic analysis in rheumatoid arthritis reveals potential therapeutic targets: Harnessing Mendelian randomization. J Pharm Biomed Anal. 2025 Jun 18;265:117038. doi: 10.1016/j.jpba.2025.117038. Epub ahead of print. PMID: 40617003.